RXST实时信号 | 通过Getagraph.com最大化利润

购买 107624 min ago

@ $51.45

发出时间: 15 Feb 2024 @ 00:15

回报率: 2.57%

上一信号: Feb 14 - 22:33

上一信号: 出售

回报率: -0.56 %

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	273 467
平均成交量	397 529
市值	1.95B
EPS	$0 ( 2024-02-28 )
下一个收益日期	( $-0.170 ) 2024-05-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-37.43
ATR14	$0.0590 (0.11%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Thunen Shelley B	Sell	8 857	Common Stock
2024-04-01	Thunen Shelley B	Sell	800	Common Stock
2024-04-01	Thunen Shelley B	Sell	8 938	Common Stock
2024-04-01	Thunen Shelley B	Sell	662	Common Stock
2024-04-01	Thunen Shelley B	Sell	200	Common Stock

INSIDER POWER
5.78
Last 100 transactions
Buy: 649 170 \| Sell: 601 875

音量相关性

長: 0.27 (neutral)

短: -0.88 (strong negative)

Signal:(47.552) Neutral

RxSight, Inc. 相关性

10 最正相关

10 最负相关
FEYE	-0.827
SVAC	-0.804

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

RxSight, Inc. 相关性 - 货币/商品

-0.44
( neutral )

-0.36
( neutral )

0.00
( neutral )

-0.43
( neutral )

-0.27
( neutral )

0.42
( neutral )

RxSight, Inc. 财务报表

Annual	2023
营收:	$89.08M
毛利润:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2023
营收:	$89.08M
毛利润:	$53.77M (60.36 %)
EPS:	$-1.410

FY	2022
营收:	$49.01M
毛利润:	$21.33M (43.52 %)
EPS:	$-2.41

FY	2021
营收:	$22.59M
毛利润:	$4.52M (19.99 %)
EPS:	$-2.59

Financial Reports:

No articles found.

RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.